Clinical pharmacokinetics of phenobarbital in neonates

European Journal of Pharmaceutical Sciences

Volumn 12, Issue 2, 2000, Pages 111-116

  Touw, D J ^a,b   Graafland, O ^a   Cranendonk, A ^a   Vermeulen, R J ^a   Van Weissenbruch, M M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Apotheek Haagse Ziekenhuizen   (Netherlands)

Author keywords

Gestational age; Neonate; Pharmacokinetics; Phenobarbital

Indexed keywords

PHENOBARBITAL;

ARTICLE; BODY SURFACE; BODY WEIGHT; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MONITORING; FEMALE; GESTATIONAL AGE; HEIGHT; HUMAN; MALE; NEWBORN; PRIORITY JOURNAL;

ANTICONVULSANTS; BODY CONSTITUTION; EPILEPSY, BENIGN NEONATAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; PHENOBARBITAL; REGRESSION ANALYSIS;

EID: 0033727389     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00145-7     Document Type: Article

References (14)

1. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I)
2. Surface area estimation: pocket calculator v nomogram
3. Relation of EEG and seizures to phenobarbital in serum
4. Phenobarbital maintenance dose requirements in treating neonatal seizures
5. Individualizing phenobarbital dosing in neonates
6. Pharmacokinetics of phenobarbital in childhood
7. Nutritional assessment and measurement of body composition in preterm infants
8. Simplified calculation of body surface area
9. Phenobarbital pharmacokinetics in neonates
10. MWPharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
11. Age and weight
12. Some suggestions for measuring predictive performance
13. Phenobarbitone population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens